Craig R. Skenes

Corporate Officer/Principal bei AERIE PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profil

Craig R.
Skenes is currently the Vice President of Business Development at Aerie Pharmaceuticals, Inc. He received his undergraduate degree and MBA from The California State University.

Aktive Positionen von Craig R. Skenes

Unternehmen	Position	Beginn
AERIE PHARMACEUTICALS, INC.	Corporate Officer/Principal	16.06.2014

Alle aktiven Positionen von Craig R. Skenes

Ausbildung von Craig R. Skenes

The California State University

Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Craig R. Skenes im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	1
Aerie Pharmaceuticals, Inc. Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX.	Health Technology